Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease-Reference-Cited by-同舟云学术

Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease

Published:2014-12-16 Issue:12 Volume:9 Page:e114086
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Michel Anne,Downey Patrick,Nicolas Jean-Marie,Scheller Dieter

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference75 articles.

1. Parkinson's disease: mechanisms and models;W Dauer;Neuron,2003

2. Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments;P Bargiotas;NeuropsychiatrDisTreat,2013

3. Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions;A Ramirez-Zamora;ExpertRevNeurother,2014

4. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series;DA Gallagher;Mov Disord,2007

5. Molecular mechanisms of L-DOPA-induced dyskinesia;P Jenner;Nat Rev Neurosci,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosynthesis and In Vitro Evaluation of [11C]tozadenant as Adenosine A2A Receptor Radioligand;Molecules;2024-02-29

2. Dimethyl Fumarate Exerts a Neuroprotective Effect by Enhancing Mitophagy via the NRF2/BNIP3/PINK1 Axis in the MPP+ Iodide-Induced Parkinson’s Disease Mice Model;Journal of Alzheimer's Disease Reports;2024-02-20

3. In vitro and in vivo activity of a novel oxamide-hydrazone hybrid derivative against triple-negative breast cancer;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-19

4. Development of the potential synthesized compound to cause triple negative breast cancer cell death through intrinsic apoptosis mechanism;2023-05-15

5. How and why the adenosine A2A receptor became a target for Parkinson’s disease therapy;International Review of Neurobiology;2023